These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9061837)

  • 1. A comparative study of several antibiotic formulations using a design based on a combination of balanced incomplete blocks and Latin squares.
    Prescott P; Ryan J; Shuttleworth P
    Stat Med; 1994 Jan; 13(1):11-21. PubMed ID: 9061837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of uniform-balanced cross-over designs for any odd number of treatments.
    Prescott P
    Stat Med; 1999 Feb; 18(3):265-72. PubMed ID: 10070673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and analysis issues for crossover designs in phase I clinical studies.
    Boon PC; Roes KC
    J Biopharm Stat; 1999 Mar; 9(1):109-28. PubMed ID: 10091913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness of crossover trials against subject drop-out - Examples of perpetually connected designs.
    Godolphin PJ; Godolphin EJ
    Stat Methods Med Res; 2019 Mar; 28(3):788-800. PubMed ID: 29145768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
    Koch GG; Amara IA; MacMillan J
    J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequentially balanced three-squares cross-over designs.
    Newcombe RG
    Stat Med; 1996 Oct; 15(20):2143-7. PubMed ID: 8910959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the repeated cross-over designs in assessing bioequivalence.
    Liu JP
    Stat Med; 1995 May 15-30; 14(9-10):1067-78; discussion 1079-80. PubMed ID: 7569501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
    Walter SD; Awasthi S; Jeyaseelan L
    Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An algorithm to minimize the number of blocks in incomplete block designs.
    MacDonald JA; Hout MC; Schmidt J
    Behav Res Methods; 2020 Aug; 52(4):1459-1468. PubMed ID: 31823224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal crossover designs for logistic regression models in pharmacodynamics.
    Waterhouse TH; Eccleston JA; Duffull SB
    J Biopharm Stat; 2006; 16(6):881-94. PubMed ID: 17146986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant Disease Severity Assessment-How Rater Bias, Assessment Method, and Experimental Design Affect Hypothesis Testing and Resource Use Efficiency.
    Chiang KS; Bock CH; Lee IH; El Jarroudi M; Delfosse P
    Phytopathology; 2016 Dec; 106(12):1451-1464. PubMed ID: 27532427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of models for average bioequivalence in replicated crossover designs.
    Willavize SA; Morgenthien EA
    Pharm Stat; 2006; 5(3):201-11. PubMed ID: 17080753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical power for nonequivalent pretest-posttest designs. The impact of change-score versus ANCOVA models.
    Oakes JM; Feldman HA
    Eval Rev; 2001 Feb; 25(1):3-28. PubMed ID: 11205523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for cross-over trials in phase III.
    Jones B; Lewis JA
    Stat Med; 1995 May 15-30; 14(9-10):1025-38. PubMed ID: 7569498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latin square designs for crossover studies balanced for carryover effects.
    Newcombe RG
    Stat Med; 1992 Feb; 11(4):560. PubMed ID: 1609187
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospectively planned cumulative meta-analysis applied to a series of concurrent clinical trials.
    Whitehead A
    Stat Med; 1997 Dec; 16(24):2901-13. PubMed ID: 9483722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balanced incomplete block design: an alternative for data collection in the optimized descriptive profile.
    Silva RCDSND; Minim VPR; Silva AND; Simiqueli AA; Della Lucia SM; Minim LA
    Food Res Int; 2014 Oct; 64():289-297. PubMed ID: 30011653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levene tests of homogeneity of variance for general block and treatment designs.
    O'Neill ME; Mathews KL
    Biometrics; 2002 Mar; 58(1):216-24. PubMed ID: 11890318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.